World
New HIV Prevention Drug Could Curb Global Cases, but US Aid Cuts Pose Hurdles
Experts at the AIDS 2026 conference highlighted that the new injectable HIV prevention drug lenacapavir could dramatically reduce global infections, but US aid cuts are undermining access. The dismantling of USAID has slashed funding for HIV prevention, threatening progress and leaving the most vulnerable without protection.
